Erythropoietin-mediated activation of functional properties of peripheral blood mononuclear cells in patients with chronic heart failure
- Authors: Poveshchenko O.V1,2, Bondarenko N.A1,2, Kim I.I1,2, Lykov A.P1,2, Surovtseva M.A1,2, Pokushalov E.A2, Romanov A.B2, Poveshchenko A.F1,2, Konenkov V.I1,2, Karaskov A.M2
-
Affiliations:
- Scientific Institute of Clinical and Experimental Lymphology
- Novosibirsk Scientific Institute of Circulating Pathology
- Issue: Vol 12, No 2 (2017)
- Pages: 82-87
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/120668
- DOI: https://doi.org/10.23868/201707019
- ID: 120668
Cite item
Abstract
Full Text
About the authors
O. V Poveshchenko
Scientific Institute of Clinical and Experimental Lymphology; Novosibirsk Scientific Institute of Circulating Pathology
Email: poveschenkoov@yandex.ru
N. A Bondarenko
Scientific Institute of Clinical and Experimental Lymphology; Novosibirsk Scientific Institute of Circulating Pathology
I. I Kim
Scientific Institute of Clinical and Experimental Lymphology; Novosibirsk Scientific Institute of Circulating Pathology
A. P Lykov
Scientific Institute of Clinical and Experimental Lymphology; Novosibirsk Scientific Institute of Circulating Pathology
M. A Surovtseva
Scientific Institute of Clinical and Experimental Lymphology; Novosibirsk Scientific Institute of Circulating Pathology
E. A Pokushalov
Novosibirsk Scientific Institute of Circulating Pathology
A. B Romanov
Novosibirsk Scientific Institute of Circulating Pathology
A. F Poveshchenko
Scientific Institute of Clinical and Experimental Lymphology; Novosibirsk Scientific Institute of Circulating Pathology
V. I Konenkov
Scientific Institute of Clinical and Experimental Lymphology; Novosibirsk Scientific Institute of Circulating Pathology
A. M Karaskov
Novosibirsk Scientific Institute of Circulating Pathology
References
- Zamilpa R., Navarro M.M., Flores I. et al. Stem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regeneration. World J. Cardiol. 2014; 6(7): 610-20.
- Hosing C. Hematopoietic stem cell mobilization with G-CSF. Methods Mol. Biol. 2012; 904: 37-47.
- Clifford D.M., Fisher S.A., Brunskill S.J. et al. Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes. Plos One 2012; 7: e37373.
- Lai W.H., Ho J.C.Y., Chan Y.C. et al. Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells. Plos One 2013; 8(3): e57876.
- Gnecchi M., Zhang Z., Ni A. et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008; 103(11): 1204-19.
- Crisostomo P.R., Markel T.A., Wang Y. et al. Surgically relevant aspects of stem cell paracrine effects. Surgery 2008; 143: 577-81.
- Pagonopoulou O., Efthimiadou A., Lambropoulou M. et al. Erythropoietin and growth factors exhibit differential angiogenic potential in mouse heart. In Vivo 2008; 22: 587-91.
- Takahashi T., Tang T., Lai N.C. et al. Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation 2006; 114: 388-96.
- Calvillo L., Latini R., Kajstura J. et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. PNAS USA 2003; 100(8): 4802-6.
- Depping R., Kawakami K., Ocker H. et al. Expression of the erythropoietin receptor in human heart. J. Thorac. Cardiovasc. Surg. 2005; 130(3): 877-8.
- Goon P.K., Lip G.Y., Boos C.J. et al. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 2006; 8: 79-88.
- Коненков В.И., Повещенко О.В., Ким И.И. и др. Влияние G-CSF на проангиогенные свойства мобилизированных клеток периферической крови у больных с хронической сердечной недостаточностью. Гены и клетки 2011; YIt3): 71-5.
- Захаров Ю.М. Цитопротекторные функции эритропоэтина. Клиническая нефрология 2009; 1: 16-21.
- Kang Y.J., Digicaylioglu M., Russo R. et al. Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders. Ann. Neurol. 2010; 68(3): 342-52.
- Liu N.M., Tian J., Wang W.W. et al. Effect of erythropoietin on mesenchymal stem cell differentiation and secretion in vitro in an acute kidney injury microenvironment. Genet. Mol. Res. 2013; 12(4): 6477-87.
- Wang P.R. Mouse adult renal progenitor cells in combination with erythropoietin or suramin - a potential new strategy for the treatment of acute kidney injury. Stem Cell Res. Ther. 2013; 4(4): 89.
- Ercan E., Bagla A.G., Aksoy A. et al. In vitro protection of adipose tissue-derived mesenchymal stem cells by erythropoietin. Acta Histochem. 2014; 116(1): 117-25.
- Santoso T., Irawan C., Alwi I. et al. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study. Acta Med. Indones. 2011; 43(2): 112-21.
- Tousoulis D., Vogiatzi G., Briasoulis A. et al. Effects of intramuscular administration of hematopoietic progenitor and coadministration oferythropoietin on blood perfusion, angiogenic factors and vascularization in a murine model of limb ischemia. Int. J. Cardiol. 2013; 169(3): 229-31.
- Pellegrini L., Bennis Y., Guillet B. et al. Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats. Neurol. Res. 2013; 35(9): 937-47.
- Bennis Y., Sarlon-Bartoli G., Guillet B. et al. Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential. J. Thromb. Haemost. 2012; 10(9): 1914-28.